Sofinnova Investments logo

Sofinnova Investments

North America, California, United States, Menlo Park

Description

Sofinnova Investments specializes in seed, startup, mid, early stage, series A, first venture round, and corporate spinouts.

Investor Profile

Sofinnova Investments has made 277 investments, with 4 in the past 12 months and 24% as lead.

Stage Focus

  • Series Unknown (25%)
  • Series B (23%)
  • Series A (20%)
  • Series C (14%)
  • Series D (9%)
  • Post Ipo Equity (4%)
  • Series E (3%)
  • Seed (1%)
  • Series F (1%)
  • Private Equity (1%)

Country Focus

  • United States (81%)
  • France (8%)
  • The Netherlands (2%)
  • Switzerland (2%)
  • United Kingdom (2%)
  • Ireland (1%)
  • Germany (1%)
  • Saint-Martin (France) (1%)
  • China (1%)
  • Belgium (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Biopharma
  • Software
  • Life Science
  • Oncology
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sofinnova Investments frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 22
venBio Partners
North America, California, United States, San Francisco
Co-Investments: 12
CA
North America, Massachusetts, United States, Boston
Co-Investments: 12
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 15
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 18
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 17
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 14
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 17
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 17
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 19

Which angels does Sofinnova Investments often collaborate with?

SH
North America, North Carolina, United States, Raleigh
Shared Deals: 1
SK
North America, California, United States, Los Angeles
Shared Deals: 1
GD
North America, Massachusetts, United States, Lexington
Shared Deals: 1
MR
North America, California, United States, Hermosa Beach
Shared Deals: 1
JF
North America, California, United States
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Sofinnova Investments?

Atsena Therapeutics

Durham, North Carolina, United States

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

BiotechnologyHealth CareTherapeutics
Series CApr 2, 2025
Amount Raised: $150,000,000
Edgewise Therapeutics

Boulder, Colorado, United States

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityApr 2, 2025
Amount Raised: $200,000,000
Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series ANov 18, 2024
Axonis Therapeutics

Boston, Massachusetts, United States

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

BiotechnologyLife ScienceMedical
Series AOct 30, 2024
Amount Raised: $115,000,000
Seaport Therapeutics

Boston, Massachusetts, United States

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 21, 2024
Amount Raised: $225,000,000
Marea Therapeutics

San Francisco, California, United States

Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.

BiotechnologyGeneticsLife Science
Series BJun 18, 2024
Amount Raised: $190,000,000
Seaport Therapeutics

Boston, Massachusetts, United States

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

BiotechnologyPharmaceutical
Series AApr 9, 2024
Amount Raised: $100,000,000
Aeovian Pharmaceuticals

San Francisco, California, United States

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AMar 28, 2024
Amount Raised: $50,000,000
Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series AMar 26, 2024
Amount Raised: $150,000,000
Capstan Therapeutics

San Diego, California, United States

Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.

BiotechnologyHealth CareTherapeutics
Series BMar 20, 2024
Amount Raised: $175,000,000